Related Experiment Video
Updated: Apr 7, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Spatial confinement-enhanced CHA system based on tetrahedral DNA nanostructures for sensitive in situ mRNA analysis
Yujie Wang1, Tongtong Pan2, Mengru Li3
1Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Cixi Biomedical Research Institute, School of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou, 325035, China.
We developed a novel DNA nanomachine (T-CHA) for sensitive detection of cancer biomarkers like UBE2C mRNA in hepatocellular carcinoma (HCC). This technology offers improved early cancer diagnosis and distinguishes cancer cells with high accuracy.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Nanotechnology
Background:
- Accurate detection of tumor-related mRNA is crucial for early cancer diagnosis but faces challenges like low biomarker abundance.
- Existing methods often lack the sensitivity and efficiency required for reliable early cancer detection.
Purpose of the Study:
- To develop a sensitive and efficient platform for detecting tumor-related mRNA, specifically UBE2C mRNA in hepatocellular carcinoma (HCC).
- To demonstrate the modular adaptability of the platform for detecting other RNA targets, such as microRNA-21 (miR-21).
Main Methods:
- Development of a three-dimensional DNA nanomachine (T-CHA) integrating catalytic hairpin assembly (CHA) and a tetrahedral DNA nanostructure (TDN).
- Utilizing T-CHA to trigger localized, cascading amplification reactions for target mRNA detection.
- Application of T-CHA to clinical tissue sections for visualizing gene expression at single-cell resolution.
Main Results:
- T-CHA achieved quantitative detection of UBE2C mRNA with a limit of detection of 8.53 fM within 30 minutes.
- The platform accurately distinguished HCC cells based on UBE2C expression levels.
- T-CHA demonstrated superior performance compared to fluorescence in situ hybridization (FISH) in visualizing heterogeneous UBE2C expression.
- T-CHA successfully detected miR-21, showcasing its adaptability for diverse RNA targets.
Conclusions:
- The T-CHA platform combines structural precision of TDN with signal amplification of CHA for robust and precise molecular diagnosis of HCC.
- T-CHA shows significant potential for early cancer diagnosis and molecular subtyping.
- The modular design of T-CHA supports its application for detecting various RNA biomarkers, paving the way for broader diagnostic applications.
More Related Videos
07:16Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection
Published on: February 9, 2024
12:20Real-time Imaging of Single Engineered RNA Transcripts in Living Cells Using Ratiometric Bimolecular Beacons
Published on: August 6, 2014